Matches in Wikidata for { <http://www.wikidata.org/entity/Q63813484> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q63813484 description "clinical trial" @default.
- Q63813484 description "ensayu clínicu" @default.
- Q63813484 description "klinisch onderzoek" @default.
- Q63813484 description "клінічне випробування" @default.
- Q63813484 description "կլինիկական փորձարկում" @default.
- Q63813484 name "Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan" @default.
- Q63813484 type Item @default.
- Q63813484 label "Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan" @default.
- Q63813484 prefLabel "Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan" @default.
- Q63813484 P1050 Q63813484-5DE60618-57F0-4DCC-B9DC-0D00B75C3A76 @default.
- Q63813484 P1132 Q63813484-4D38A5CB-ABED-4E8C-B53E-4095E05AF4DC @default.
- Q63813484 P1476 Q63813484-00044B6B-DD98-4C1F-9718-BBD020BA5163 @default.
- Q63813484 P2899 Q63813484-440D7E19-2D04-4311-B6AB-E796FFC5DEC1 @default.
- Q63813484 P3098 Q63813484-148852E7-22C7-4598-A06F-68B573F13438 @default.
- Q63813484 P31 Q63813484-1F564586-931A-4186-989A-AFBF033B2603 @default.
- Q63813484 P4135 Q63813484-AE6C63C1-4641-4312-BF04-744F45870039 @default.
- Q63813484 P4844 Q63813484-C442ABF4-2158-4029-AD00-7DFF896A4A7E @default.
- Q63813484 P580 Q63813484-0BA1476D-E95C-4E4C-8AD0-CF1EEA408B1E @default.
- Q63813484 P582 Q63813484-61712920-2C13-46EC-B1F6-C77E512DDBCF @default.
- Q63813484 P6099 Q63813484-03F04365-6931-435B-A1B2-965A9CCEE5A9 @default.
- Q63813484 P6099 Q63813484-CD3A4A7B-062B-4BC4-A994-528C2EDA7B3F @default.
- Q63813484 P8363 Q63813484-2F2F51B4-8AE7-4D83-902D-075D209BFBD7 @default.
- Q63813484 P1050 Q12206 @default.
- Q63813484 P1132 "+312" @default.
- Q63813484 P1476 "A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 When Used in Combination With Sulfonylurea in Subjects With Type 2 Diabetes in Japan" @default.
- Q63813484 P2899 "+20" @default.
- Q63813484 P3098 "NCT01318083" @default.
- Q63813484 P31 Q30612 @default.
- Q63813484 P4135 "+64" @default.
- Q63813484 P4844 Q425027 @default.
- Q63813484 P580 "2008-08-01T00:00:00Z" @default.
- Q63813484 P582 "2009-04-01T00:00:00Z" @default.
- Q63813484 P6099 Q42824440 @default.
- Q63813484 P6099 Q42824827 @default.
- Q63813484 P8363 Q78089383 @default.